Blog

Food inflation on the rise – list

(NaturalNews) If you’ve read any economic news lately, you’ve probably been treated to a host of stories touting a “strong” U.S. recovery, really low unemployment, and very little inflation. And, if you’re like most working class Americans, you’ve probably read those stories while…

FDA again expands usage of Regeneron eye drug Eylea

(Reuters) – U.S. health regulators on Wednesday approved Regeneron Pharmaceuticals Inc’s big-selling eye drug Eylea to treat diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in adults. The Food and Drug Administration decision marked the fourth approval for Eylea, an injectable medicine sold in partnership with French drugmaker Sanofi. “Today’s approval gives patients with diabetic retinopathy and diabetic macular edema another therapy to treat